Asked by: Lord Ramsbotham (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what progress they have made with plans to collect and report the length of stays in secure inpatient care.
Answered by Lord O'Shaughnessy
NHS England is currently carrying out a review of the information collected in relation to all mental health services. This review will include the collection and reporting of data on the length of stays in secure inpatient care.
It is expected that information on the length of stays will be reported by NHS England going forward.
Asked by: Lord Ramsbotham (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether draft regulations for making Naloxone more widely available will be published in draft ahead of the October 2015 implementation, to enable organisations including police, hostels and drugs misuse services to make advance plans.
Answered by Earl Howe - Shadow Deputy Leader of the House of Lords
Naloxone has a vital role in saving lives and we are committed to widening its use in England. We have accepted the recommendation from the Advisory Council on the Misuse of Drugs to make this life-saving medicine available more widely and Departmental officials are drafting new regulations to give effect to this decision. This legislative change is due to commence in October 2015.
Public Health England has recently published advice for commissioners and providers on the provision of take-home naloxone for reversing overdose in people who use heroin and other opiates, so that commissioners and providers can take action, both now and following the October 2015 legislative change, to widen the supply of naloxone.
In addition, the issue of naloxone supply is also being considered by the independent expert group updating the 2007 drug misuse clinical guidelines, Drug Misuse and Dependence: UK Guidelines on Clinical Management.
As it is formulated as an injectable medicine, naloxone does not meet the criteria set out in legislation for classification as an over-the-counter medicine.
Amended regulations will be publicly available when they are laid before Parliament.
Asked by: Lord Ramsbotham (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether they have given consideration to making Naloxone an over-the-counter drug in England.
Answered by Earl Howe - Shadow Deputy Leader of the House of Lords
Naloxone has a vital role in saving lives and we are committed to widening its use in England. We have accepted the recommendation from the Advisory Council on the Misuse of Drugs to make this life-saving medicine available more widely and Departmental officials are drafting new regulations to give effect to this decision. This legislative change is due to commence in October 2015.
Public Health England has recently published advice for commissioners and providers on the provision of take-home naloxone for reversing overdose in people who use heroin and other opiates, so that commissioners and providers can take action, both now and following the October 2015 legislative change, to widen the supply of naloxone.
In addition, the issue of naloxone supply is also being considered by the independent expert group updating the 2007 drug misuse clinical guidelines, Drug Misuse and Dependence: UK Guidelines on Clinical Management.
As it is formulated as an injectable medicine, naloxone does not meet the criteria set out in legislation for classification as an over-the-counter medicine.
Amended regulations will be publicly available when they are laid before Parliament.
Asked by: Lord Ramsbotham (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what action they are taking to improve access to Naloxone in England.
Answered by Earl Howe - Shadow Deputy Leader of the House of Lords
Naloxone has a vital role in saving lives and we are committed to widening its use in England. We have accepted the recommendation from the Advisory Council on the Misuse of Drugs to make this life-saving medicine available more widely and Departmental officials are drafting new regulations to give effect to this decision. This legislative change is due to commence in October 2015.
Public Health England has recently published advice for commissioners and providers on the provision of take-home naloxone for reversing overdose in people who use heroin and other opiates, so that commissioners and providers can take action, both now and following the October 2015 legislative change, to widen the supply of naloxone.
In addition, the issue of naloxone supply is also being considered by the independent expert group updating the 2007 drug misuse clinical guidelines, Drug Misuse and Dependence: UK Guidelines on Clinical Management.
As it is formulated as an injectable medicine, naloxone does not meet the criteria set out in legislation for classification as an over-the-counter medicine.
Amended regulations will be publicly available when they are laid before Parliament.